Verum Health
Performance Protocol

IGF-1 LR3 · 5ML

IGF-1 LR3 is a long-acting analogue of Insulin-like Growth Factor 1, studied for anabolic, tissue repair, and metabolic effects. Physician-reviewed. Prescription required.

Performance Recovery Prescription Required
What It Is
IGF-LR3 5ML

Mechanism of Action

IGF-1 LR3 is a synthetic analog of Insulin-like Growth Factor 1, modified to have longer half-life (~20–30 hours) and reduced binding to IGF-binding proteins (IGFBPs). IGF-1 LR3 acts as a direct anabolic and mitogenic growth factor, primarily through activation of the IGF-1 receptor (IGF1R).

IGF-1 LR3 has been studied for its role in muscle protein synthesis, cell growth, glucose metabolism, and tissue repair. Its reduced IGFBP binding increases bioavailability and potency compared to native IGF-1. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

Mechanism Biological Effect
IGF1R activation Protein synthesis, cell growth, survival
PI3K/AKT/mTOR signaling Muscle hypertrophy, tissue repair
Ras/MAPK pathway Cell proliferation and differentiation
Reduced IGFBP binding Increased bioavailability and potency
Anti-apoptotic effects Protection of cells during stress
Glucose metabolism modulation Enhanced glucose uptake and glycogen synthesis
Candidate Profile

Who It's Designed For

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with IGF-1 LR3 protocol candidates in clinical practice:

Muscle Development

Individuals pursuing physician-supervised anabolic support for lean mass development.

Tissue Repair

Individuals recovering from significant musculoskeletal injury requiring intensive tissue repair support.

Performance Athletes

High-output athletes under physician supervision seeking advanced recovery and performance support.

Metabolic Support

Individuals with metabolic goals where IGF-1 mediated glucose utilization may be clinically relevant.

Determine your candidacy

A physician will review your intake and make eligibility determination within 24–48 hours.

Outcomes & Timeline

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Weeks 1–2
Initial IGF-1R activation. Anabolic signaling begins. Individual outcomes may differ.
Weeks 2–6
Progressive improvements in protein synthesis and recovery may be observed. Results vary.
Weeks 6–8
Protocol completion. Physician evaluation for continuation or cycling. Mandatory review required.
Dosing Overview

Protocol Structure

Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.

Typical Range

20–100 mcg/day

Administration

Subcutaneous injection

Duration

4–8 weeks (physician-determined)

Frequency

Once daily (physician-determined)

These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.

What's Included

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Contraindications & Safety Notes

Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.

Active malignancy or history of cancer: IGF-1 analogues are contraindicated in active cancer contexts. Full disclosure required.
Diabetes or insulin resistance: IGF-1 affects glucose metabolism. Close physician monitoring required.
Pregnancy or lactation: Not indicated. Contraindicated.
Current medications: Disclose all medications and supplements. Interactions reviewed at consultation.
FAQ

Common Questions

This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness. Do not combine protocols without explicit physician guidance.
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized. Reorder notification is sent 10 days before your protocol completes.
IGF-LR3
VERUM HEALTH
From $290
Prescription required
Begin Consultation
How it works:
Add to cart → complete physician intake → doctor reviews within 24–48h → approval → pharmacy ships direct.
Refill Policy: Approved protocols include 4 months of refills. Auto-refill available after initial approval.